An additional mechanism whereby MYCN can overcome p53-mediated apoptosis is through reduced expression of CHD5, a tumor suppressor gene (TSG) mapping to 1p36.31, which is a region commonly deleted in neuroblastoma and frequently correlated with MYCN amplification (Figure 2). Here, MYCN is linked to neuroblastoma.